Blue Jet Healthcare Limited reported a stellar financial performance for the fourth quarter ended March 31, 2025, with net profit rising 177% year-on-year to ₹110 crore, compared to ₹39.65 crore in Q4 FY24. The company benefited from strong revenue growth and improved operating leverage.
Total income for Q4 FY25 stood at ₹352.67 crore, up from ₹192.78 crore in the same period last year. Revenue from operations rose to ₹340.45 crore in Q4 FY25, up from ₹183.95 crore in Q4 FY24.
Total expenses for the quarter came in at ₹205.46 crore, up from ₹138.62 crore a year earlier. Despite the rise in costs, the operating margin remained healthy, with profit before tax increasing to ₹147.21 crore from ₹54.15 crore in Q4 FY24.
For the full year FY25, net profit surged to ₹305.20 crore, up 87% from ₹163.76 crore in FY24. Total income for the year stood at ₹1,076.24 crore, compared to ₹740.46 crore in the previous financial year, reflecting a growth of over 45%. Revenue from operations for FY25 was ₹1,029.98 crore, compared to ₹711.60 crore in FY24.
The performance was driven by higher operational efficiency, stable employee costs, and favorable inventory adjustments over the year.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
